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TA (toxin–antitoxin) systems are widely distributed amongst
bacteria and are associated with the formation of antibiotic
tolerant (persister) cells that may have involvement in chronic
and recurrent disease. We show that overexpression of the
Burkholderia pseudomallei HicA toxin causes growth arrest and
increases the number of persister cells tolerant to ciprofloxacin
or ceftazidime. Furthermore, our data show that persistence
towards ciprofloxacin or ceftazidime can be differentially
modulated depending on the level of induction of HicA
expression. Deleting the hicAB locus from B. pseudomallei
K96243 significantly reduced persister cell frequencies following
exposure to ciprofloxacin, but not ceftazidime. The structure
of HicA(H24A) was solved by NMR and forms a dsRBD-like
(dsRNA-binding domain-like) fold, composed of a triple-stranded
β-sheet, with two helices packed against one face. The surface
of the protein is highly positively charged indicative of an RNA-
binding protein and His24 and Gly22 were functionality important
residues. This is the first study demonstrating a role for the HicAB
system in bacterial persistence and the first structure of a HicA
protein that has been experimentally characterized.
Key words: Burkholderia pseudomallei, HicAB, melioidosis,
persister cell, toxin–antitoxin.
INTRODUCTION
Burkholderia pseudomallei is a motile Gram-negative bacterium
that normally resides in soil in South-East Asia and northern
Australia [1]. It is an opportunistic human pathogen, entering
the host by inhalation, skin abrasions or ingestion and causing the
disease melioidosis [2]. In spite of antibiotic intervention,
melioidosis has a mortality rate of up to 44 % in endemic areas,
and it is the third most frequent cause of death from infectious
diseases in north-east Thailand [3]. Up to 15% of patients relapse
following completion of therapy [4]. The bacterium is considered
to be a potential bioterrorism agent, partly owing to its ability to
infect by the airborne route [1]. Little is known about the
mechanisms by which this bacterium establishes disease or
the mechanisms that allow it to establish infections that are
refractory to antibiotic treatment [2,5].
Persister cells were first identified in the 1940s. Staphylococcus
aureus cultures treated with supra-lethal doses of antibiotic
showed biphasic killing, with a subpopulation of bacterial
cells surviving the treatment [6]. When these antibiotic-tolerant
bacteria were grown in fresh media and exposed to antibiotic,
they generated similar frequencies of survivors, showing they
were not a genetically defined subpopulation. Instead, tolerance
appeared to be due to phenotypic variation within the bacterial
population. More recently, it has been suggested that persister
cells act as a reservoir for chronic infections [7,8], and it has been
shown that a broad range of bacterial species can form persister
cells. Escherichia coli can form persister cells at a frequency
of between 10− 6 and 10− 5 in the exponential phase and up to
1% in the stationary phase [9,10], whereas our data indicate that
B. pseudomallei can form persister cells at frequencies of up to
10− 1 (C. M. Hemsley, J. X. Luo, C. Andreae, C. Butler, O. S.
Soyer and R. W. Titball, unpublished work). A current model
suggests that persister cells are generated as a consequence of
fluctuations in the expression levels of certain genes and that this
noise can be amplified by external signals [11]. Indeed, a series of
quorum sensing-like chemicals such as indole, CSP (competence
signalling protein) and pyocynanin have been associated with the
formation of E. coli, Streptococcus mutans and Pseudomonas
aeruginosa persister cells [12–14].
The genetic mechanisms that underpin persister cell formation
are poorly defined, but there is evidence that TA (toxin–
antitoxin) modules play a role. Transcriptome profiling of E.
coli and Mycobacterium tuberculosis persister cells has revealed
differential expression of TA systems [10,15]. In E. coli, exposure
to ciprofloxacin increased TisB toxin levels and, in parallel,
increased persister cell numbers [16]. However, the most direct
evidence for a role of TA modules in persister cell formation
is derived from studies showing that mutations in the HipBA
TA system of E. coli can modulate the frequency of persister
cell formation [17–19]. Similarly, in M. tuberculosis it has
been reported that inactivation of the RelE genes influences the
frequency of persister cell formation [20].
We identified recently four candidate TA systems in B.
pseudomallei [21]. TA systems can be categorized into five
groups (type I, II, III, IV or V) based on the gene product [22–
25]. Typically, one gene encodes a 95–135-amino-acid toxin.
These toxins can interact with cellular components such as
RNA, ribosomes or DNA gyrase, resulting in a bactericidal or
bacteriostatic response within the cell [23]. The cognate antitoxin
Abbreviations: CFU, colony-forming units; dsRBD-like, dsRNA-binding domain-like; MIC, minimum inhibitory concentration; TA, toxin–antitoxin; TBST,
TBS supplemented with 1% (v/v) Tween-20.
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The chemical shifts and structure reported for HicA toxin from Burkholderia pseudomallei will appear in the Biological Magnetic Resonance Data Bank
(BMRB) under accession number 19464 and in the PDB under code 4C26 respectively.
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Table 1 Bacterial strains used or created in the present study
Bacterial strain Genotype/comments Source
E. coli K-12 MG1655 F− λ− ilvG-rfb-50 rph-1 Laboratory strain collection
E. coli DH5α λpir lacU169(lacZM15), recA1, endA1, hsdR17, thi-1, gyrA96, relA1, λpir phage lysogen Laboratory strain collection
E. coli S17-1 λpir TpR SmR recA, thi, pro, hsdR-M+ RP4:2-Tc:Mu:Km Tn7 λpir Laboratory strain collection
E. coli DH5α (pRK2013) lacU169(lacZM15), recA1, endA1, hsdR17, thi-1, gyrA96, relA1, pRK2013 (KmR
oriColE1 RK2-Mob+ RK2-Tra+ )
Laboratory strain collection
E. coli Rosetta(DE3)pLysS F− ompT hsdSB(RB − mB − ) gal dcm λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])
pLysSRARE (CamR)
Novagen
E. coli XL-10 Gold endA1 glnV44 recA1 thi-1 gyrA96 relA1 lac Hte (mcrA)183 (mcrCB-hsdSMR-mrr)173
tetR F’[proAB lacIqZM15 Tn10(TetR Amy CmR)]
Stratagene
B. pseudomallei K96243 Clinical isolate Laboratory strain collection
B. pseudomallei K96243 ΔhicAB K96243 derivative. Unmarked deletion ΔBPSS0390-0391 The present study
(RNA or protein) binds to the toxin and blocks its activity [26].
The toxin and antitoxin show strong inter-dependence, with the
antitoxin usually being indispensable.
One of the TA systems we identified in B. pseudomallei was
homologous to the E. coli HicBA system. The E. coli HicA
toxin induces cleavage of mRNA and tmRNA (transfer-messenger
RNA), thereby preventing translation [27]. The E. coli hicAB locus
is transcribed in response to amino acid and carbon starvation and
HicA activity is dependent on the Lon protease. This protease
degrades the unstable HicB antitoxin, which acts as an auto-
repressor of the locus, subsequently allowing transcription of the
genes in response to starvation [27]. In E. coli, the hicBA system
has been shown to play a role in growth, with overexpression of
the toxin resulting in bacteriostasis [27]. Expression of hicB was
able to neutralize hicA-induced bacteriostasis. We have shown
similar phenotypes when B. pseudomallei K96243 HicA or HicA
and HicB were expressed in E. coli MG1655 [21]. However, little
is known about the biological roles of HicBA.
The aim of the present study was to investigate the biological
role(s) of the B. pseudomallei hicAB system and to establish how
the structure of the toxin is related to these roles. We show through
overexpression and deletion of hicA a role for this toxin in the
generation of persister cells. Using mutagenesis and structure
analysis, we also reveal residues that are critical for the biological
activity of HicA and suggest a function for the toxin in RNA
degradation. The present study is the first to demonstrate a role for
the HicAB system in bacterial persistence and the first structure
of a HicA toxin that has been experimentally validated.
EXPERIMENTAL
Bacterial strains, growth conditions and chemicals
Bacterial strains used in the present study are listed in Table 1.
Unless otherwise stated, bacteria were grown in LB broth
at 37 ◦C with shaking (200 rev./min) or on LB agar plates at
37 ◦C. Where appropriate, the medium was supplemented with
100 μg/ml ampicillin (Sigma–Aldrich) for selection of pBAD/His
(Invitrogen), 15 μg/ml tetracycline for selection of pME6032,
50 μg/ml or 300 μg/ml trimethoprim for selection of
pSCrhaB3, 50 μg/ml kanamycin for selection of pET26-b and
25 μg/ml chloramphenicol for maintenance of the Rosetta
plasmid. Where indicated, glucose, arabinose or rhamnose were
added to a final concentration of 0.2% or IPTG was added to a
final concentration of 25 mM or 0.5 mM. Autoinduction media
and labelled media were prepared as described previously [28].
Construction of plasmids
The hicA and hicB genes were PCR amplified from
B. pseudomallei K96243 genomic DNA by Hotstart taq
polymerase (Qiagen). hicA was amplified using primers
hicA_forward (5′-GGAGCTCGCCATGGCTATGAACTCATC-
GAAGCTGATCC-3′) and hicA_reverse (5′-GAATTCTCACA-
GGCCGGCGGATTTC-3′) and cloned into NcoI- and EcoRI-
digested pBAD/His (Invitrogen) to create pBAD-hicA or
primers hicAtag_forward (5′-CGCCGAGCTCATGAAC-
TCATCGAAGCTGATCC-3′) and hicA_reverse and cloned into
SacI- and EcoRI-digested pBAD/His to create pBAD/His-hicA.
pSCrhaB3/His-hicA was created by digesting pBAD/His-hicA
with NcoI and HindIII and the isolated hicA cassette was cloned
into the corresponding sites of pSCrhaB3 [29]. pET26-b/His-
hicA (H24A) was made by digesting pBAD/His-hicA (H24A)
with NcoI and EcoR1 and the isolated hicA (H24A) cassette
was cloned into the respective sites of pET26-b (Novagen).
The hicB gene was amplified using primers hicB_forward
(5′-GAGCTCATGGAATTTCCCATCGCAGTG-3′) and hicB_
reverse (5′-CCATGGTTATGCGTGCCTAACTTTGCC-3′) and
cloned into NcoI- and SacI-digested pME6032 [30].
Construction of the B. pseudomallei hicAB mutant
PCR was used to amplify both 600 bp upstream of
the HicAB locus using primers hicAB_LF_1 (5′-ATAT-
AACCCGGGTCTCGTGCTGACCGGCCC-3′) and hicAB_
LF_2 (5′-CGATATTTAGCGGCCGCCATTAGCTCCCCCGAA-
TGTC-3′) and 600 bp downstream using hicAB_RF_1 (5′-GA-
GCTAATGGCGGCCGCTAAATATCGCGTGCGCCTGTA-3′)
and hicAB_RF_2 (5′-GAGCTCATGGTCGCTGGATTGGGTGT-
3′). The PCR product also contained regions of sequence that
were specific for the start and end of the hicAB locus in order
for homologous recombination to occur. The upstream and
downstream PCR products were used as template DNA for a
second recombinant PCR using hicAB_LF_1 and hicAB_RF_2
primers to create the knockout cassette, which was cloned into
pDM4 [29] via the XmaI and SacI restriction sites. The resulting
plasmid was transformed into E. coli S17λ and then conjugated
into B. pseudomallei K96243 to create a merodiploid strain.
Colonies were plated on to LB agar supplemented with 10%
(w/v) sucrose to drive sacB expression in pDM4 and promote
recombination. hicAB mutants were confirmed by PCR and
sequencing of the resulting DNA fragment.
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Co-expression assay
Co-expression was performed as described previously [21].
Briefly, early exponential phase cultures of E. coli pBAD/His-
hicA (or mutant allele)/pME6032-hicB were supplemented with
0.2% arabinose and IPTG to induce expression of hicA and hicB
respectively for 2 h. The CFU (colony-forming units) fold change
was calculated as the difference between CFU observed after 2 h
of expression, compared with that observed before expression.
Persister cell assay
For E. coli MG1655/pBAO-hicA/pME6032-hicB, overnight
cultures were diluted 1:100 in 30 ml of fresh LB supplemented
with antibiotic for plasmid selection and grown at 37 ◦C and
shaking at 200 rev./min until the D590 of the culture reached
approximately 0.1. Cultures were supplemented with either 0.2%
glucose or 0.002–0.2% arabinose to repress or induce expression
of the toxin. These cultures were incubated for 3 h at 37 ◦C,
200 rev./min. After standardizing to 2 × 108/ml cells in LB broth,
500 μl of culture was mixed with 500 μl of 200 × MIC (minimum
inhibitory concentration) of antibiotic in a 24-well plate. Plates
were incubated for up to 30 h at 37 ◦C. At the indicated time points,
cultures were washed twice in LB broth. Samples were serially
diluted and plated on to LB plates supplemented with ampicillin,
tetracycline and 1 mM IPTG to induce antitoxin expression
from the pME6032 vector. Persister frequency was calculated
as CFU at 24 h divided by CFU at T0. B. pseudomallei K96243
hicAB/pSCrhaB3-hicA was treated as above, except that cultures
were supplemented with 0.2% glucose or 0.2% rhamnose to
repress or induce expression of the toxin. These cultures were
incubated for 4 h at 37 ◦C, 200 rev./min before treating with
antibiotic. Cultures were plated on to LB agar supplemented with
trimethoprim and 0.2 % glucose. For B. pseudomallei K96243 and
B. pseudomallei K96243 hicAB, ∼108 (D590 = 0.1) stationary or
early exponential phase cells were incubated with 100 × MIC
ciprofloxacin or ceftazidime for the indicated time in a 24-well
plate. Cells were washed in LB broth and plated on to LB agar
for enumeration.
Site-directed mutagenesis
Site-directed mutagenesis was carried out on pBAD/His-
hicA toxin DNA using the QuikChange® lightning kit
(Agilent), following the manufacturer’s instructions. Plasmid
DNA containing the mutation was transformed into XL10-gold
ultracompetent cells. Mutations were confirmed by sequencing.
Large-scale protein expression
Overnight cultures of E. coli Rosetta(DE3) harbouring pET26-b
constructs were grown in a 5 ml volume of LB supplemented with
antibiotic. Cultures were diluted 1:100 in four 100 ml aliquots
of ZYM-5052 autoinduction medium [28] supplemented with
50 μg/ml kanamycin and 25 μg/ml chloramphenicol. Cultures
were incubated at 300 rev./min, 37 ◦C until reaching mid-
exponential phase. The temperature was then reduced to 20 ◦C
and growth continued overnight. For 13C,15N-labelling, overnight
cultures were grown in LB broth before diluting 1:100 in 2 litres
of fresh LB. These cultures were grown to a D590 of approximately
0.8–0.9 before harvesting the cultures at 3000 g for 10 min
in sterile 250 ml tubes to collect the cell pellets. The cell
pellets were then washed in PBS before resuspending in 500 ml
[13C,15N]N-5052 medium (replacing all carbon sources with 4 g/l
[13C]glucose) [28]. The cultures were incubated at 37 ◦C for
a further 1 h and 0.5 mM IPTG was then added to induce
expression of the cloned hicA(H24A) gene. The temperature
was reduced to 20 ◦C for maximal expression and grown
overnight.
Protein extraction
Bacterial cultures were harvested by centrifugation at 12000 g
for 10 min. The supernatant was then discarded. The cell
pellet was resuspended in lysis mixture [10 μl of benzonase,
10 μl of lysozyme and 10 ml of Bugbuster (Novagen) per
1 g of cell pellet] by vortex-mixing and then incubated on a
rocker for 30 min until the cell mixture appeared translucent.
Following lysis, the cell debris was harvested by centrifugation at
16000 g for 20 min. The supernatant was collected for subsequent
purification.
To check for expression of histidine-tagged proteins, 1 ml of
cell culture at a cell density of D590 of 1.0 was harvested by
centrifugation for 2 min at 17000 g. Cell pellets were resuspended
in a lysis mixture (100 μl of Bugbuster, 1 μl of benzonase and
1 μl of lysozyme), incubated and then centrifuged for 1 min at
17000 g to separate the soluble and insoluble material.
Protein purification
Cell lysate containing histidine-tagged protein was purified
using nickel-affinity-based column systems (His GraviTrap, GE
Healthcare) following the manufacturer’s protocol. The protein
was de-salted by running through a PD-10 desalting column
(GE Healthcare). The PD-10 columns were first equilibrated with
25 ml TBS (20 mM Tris/HCl, pH 7.4, and 150 mM NaCl) or PBS
(20 mM phosphate, pH 7.4, and 150 mM NaCl). The histidine
tag was removed by incubating the protein with enterokinase
(New England Biolabs) for 16 h at 23 ◦C. A Superdex 75 16/60
HR column (GE Healthcare) was used for size-exclusion gel
chromatography to exclude any impurities from the protein
preparation. The protein was concentrated using an Amicon
Ultra-15 Centrifugal Filter Unit with Ultracel 3-kDa membrane
by centrifugation at 3200 g, 4 ◦C. Protein concentration was
determined using a Nanodrop 1000 (Thermo Scientific). An
extinction coefficient of 0.863 at λ= 280 nm was used for the
calculation as determined using Biology workbench [30].
Protein detection
Samples were boiled at 95 ◦C for 5 min in loading dye before
electrophoresis on Novex SDS/PAGE (4–12% gels) (Invitrogen).
Following separation, the protein was stained using Simply Blue
(Invitrogen). Protein was blotted on to a nitrocellulose membrane
using an iBlot dry blotting system (Invitrogen) for 5–7 min at 20–
23 V. The membrane was stored at 4 ◦C overnight in TBST [TBS
supplemented with 1% (v/v) Tween-20] containing 3 % (w/v)
BSA for blocking. It was then incubated with TBST plus 3 %
(w/v) BSA containing anti-xpress epitope antibody (Invitrogen)
diluted 1:5000 and incubated for 1 h at room temperature (19 ◦C).
The membrane was washed three times in TBST before adding
secondary horseradish peroxidase-conjugated goat anti-mouse
antibody [1:10000 dilution in TBST plus 3% (w/v) BSA].
The wash steps were repeated as described above. The protein
was detected using SuperSignal West Femto Substrate (Thermo
Scientific) and chemiluminescence on a Chemidoc imager
equipped with QuantityOne software (Bio-Rad Laboratories).
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Figure 1 Killing of B. pseudomallei with 100 × MIC (200 μg/ml) ciprofloxacin or ceftazidime over 30 h
(a) Stationary phase cultures (D590 = 3.0), (b) exponential phase (D590 = 0.2). The data are shown as the means +− S.E.M. for at least two biological repeats.
NMR spectroscopy
The concentration of the final NMR sample was typically 1 mM
dissolved in PBS (20 mM phosphate and 150 mM NaCl) with
10% (v/v) 2H2O. All NMR experiments were acquired at 25 ◦C
on a cryoprobe-equipped Varian VNMRS 600 MHz spectrometer.
The backbone resonances were assigned using HNCA
and HNCO spectra and side-chain resonances using 3D 15N-
edited TOCSY, HCCH-TOCSY and 13C-edited NOESY spectra.
Distance restraints for structure calculations were derived from
aliphatic and aromatic 13C-edited and 15N-edited NOESY spectra
as well as a 2D 1H-1H NOESY spectrum recorded at 20 ◦C. All
of the NMR data were processed using NMRPipe [31], and the
spectra were visualized and assigned using CcpNmr Analysis
version 2.2 [32]. Structure calculations were performed using
Aria 2.3 [33] using spin diffusion correction throughout, network
anchoring in the first three iterations, and 8000 cooling steps in
both the cool1 and cool2 phases. Structures (100) were calculated
in iteration 8, of which the ten lowest energy structures were
further water refined. PSVS 1.4 [34] and CING [35] were used
to validate the structures and NMR data. The chemical shifts and
structural restraints were deposited with the Biological Magnetic
Resonance Data Bank (BMRB) [36] under accession number
19464. The structure was deposited with the PDB under code
4C26.
RESULTS AND DISCUSSION
B. pseudomallei forms antibiotic-tolerant persister cells
First, we investigated persister cell formation in B. pseudomallei
K96243 using ceftazidime and ciprofloxacin. Ceftazidime is
routinely used in front-line treatment of melioidosis [2], whereas
the use of ciprofloxacin to treat melioidosis is currently being
investigated [37].
Exponential or stationary phase B. pseudomallei cultures were
standardized to a D590 of 0.1, incubated with either 100 × MIC
(200 μg/ml) of ceftazidime or ciprofloxacin and the number
of culturable cells determined over 30 h by plating on to LB
agar (Figure 1). Killing of stationary phase B. pseudomallei by
either antibiotic occurred over the first 24 h (Figure 1a). Further
incubation did not result in further cell death, but revealed
a population of cells that could tolerate the antibiotic. This
subpopulation equated to approximately 10− 3 (0.1%) and 10− 1
(10%) of the total bacterial population for ciprofloxacin and
ceftazidime respectively. Our finding that cefatzidime, a beta-
lactam antibiotic, was active against stationary phase cultures is
in accordance with the definition of the stationary growth phase
of bacterial cultures, where there may be balanced growth and
death of B. pseudomallei cells [38].
When exponential phase B. pseudomallei were exposed to
ceftazidime, approximately 5% of the population survived after
30 h (Figure 1b). When cultures were treated with ciprofloxacin,
cell numbers dropped by approximately 250-fold after 8 h and
were below detectable levels of <103 CFU/ml [<10− 5 (0.001%)
survivor frequency] after 24 h (Figure 1b).
After treatment of either the exponential or stationary phase
cultures with antibiotic, we checked that the subpopulation
of surviving bacteria were not spontaneous antibiotic-resistant
mutants. Colonies were re-streaked in parallel on to LB agar
or LB agar containing 10 × MIC ciprofloxacin or ceftazidime
respectively. Bacterial growth only occurred on LB agar and not
on LB agar plus antibiotic (results not shown).
Overall, our findings that the treatment of B. pseudomallei
cultures with otherwise supra-lethal doses of antibiotic resulted
in biphasic killing, and that survivors were not spontaneous
antibiotic-resistant mutants, confirms the presence of persister
cells [39–41]. Our finding that the frequency of B. pseudomallei
persister cells was lower in exponential phase cultures than in
stationary phase cultures is similar to the results reported in E. coli
[42]. These differences in frequencies of persisters revealed after
exposure to ciprofloxacin or ceftazidime suggests the presence of
different persister populations in B. pseudomallei.
hicA overexpression causes growth inhibition in B. pseudomallei
K96243 ΔhicAB
We have shown previously that expression of the B. pseudomallei
HicA toxin in E. coli resulted in the rapid cessation of bacterial
growth and a reduction in the number of culturable cells [21].
These phenotypes were reversible on co-expression of the cognate
HicB antitoxin [21], confirming that HicA acts bacteriostatically.
We next investigated whether overexpression of HicA
in B. pseudomallei K96243 resulted in growth inhibition. The
B. pseudomallei hicA gene was cloned into the broad host range
plasmid pSCrhaB3, and the plasmid was conjugated into B.
pseudomallei K96243 wild-type.
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Figure 2 Culturability of a ΔhicAB mutant of B. pseudomallei containing
the plasmid cloned hicA gene
Expression of hicA was induced with 0.2 % rhamnose or repressed with 0.2 % glucose. At the
times indicted, samples were plated on to LB agar and colonies enumerated. The data are shown
as the means +− S.E.M. for three biological repeats. *P < 0.05, following an unpaired Student’s
t test as determined using the Holm–Sidak method for multiple comparisons.
Cultures of wild-type B. pseudomallei harbouring pSCrhaB3-
hicA grew similarly when glucose or rhamnose was added to
repress or induce expression (results not shown).
This lack of toxicity of hicA in wild-type B. pseudomallei
K96243 may be due to the expression of the endogenous
chromosomally encoded HicB sequestering the toxin. Other
groups have also reported the lack of toxic activity after expressing
toxins in the wild-type host of other bacterial species [43,44]. To
test this possibility, we constructed a B. pseudomallei K96243
mutant lacking the hicAB locus (ΔhicAB) and transformed the
HicA-expressing plasmid (pSCrhaB3-hicA) into this strain.
When treated with glucose the number of culturable bacteria
increased ∼20-fold over the next 8 h (Figure 2). In contrast,
when rhamnose was added to induce hicA expression, the number
of culturable bacteria increased for the first 2 h (∼5-fold), but
then declined to levels significantly lower than the control
(Figure 2). Control B. pseudomallei K96243ΔhicAB harbouring
empty pSCrhaB3 plasmid grew similarly in medium containing
glucose or rhamnose (results not shown) confirming that these
results were a consequence of the specific induction of hicA
expression.
Although we observed the cessation of growth when hicA was
expressed in the ΔhicAB mutant of B. pseudomallei, we did
not see the loss of culturability (i.e. a decline in CFU) that we
reported previously when hicA was expressed in E. coli [21]. This
might reflect a number of possible differences between the B.
pseudomallei and E. coli hosts including differences in the levels
of expression of hicA, different targets of HicA, variation in the
stability of the proteins or the ability of other antitoxins present
in these host cells to partially neutralize the activity of HicA.
Overexpression of hicA in E. coli reduces bacterial killing by
ceftazidime or ciprofloxacin
We next investigated the effect of B. pseudomallei HicA on E.
coli persister cell formation by exploiting the ability of HicA
to render cells non-culturable and the ability of HicB to rescue
the culturability of cells [21]. In this assay, hicA expression was
induced, the cells exposed to antibiotic and then plated on to
agar containing IPTG to induce hicB expression and restore
culturability [21]. This way, we could measure whether the
dormancy induced by hicA expression had provided resistance
to antibiotics. For these studies, we used E. coli MG1655
encoding the hicA toxin cloned into pBAD/His and the hicB
antitoxin cloned into pME6032 (i.e. E. coli containing hicA
and hicB on different plasmids and expressed from different
promoters). Western blotting of an E. coli MG1655 pBAD/His
hicA/pME6032-hicB cell lysate following arabinose induction
confirmed promoter-driven hicA expression. Conversely, under
glucose repression, no detectable band was present (results not
shown).
Subsequently, this strain was grown to early exponential phase
and hicA expression was induced with 0.2 % arabinose for 3 h.
Killing by 100 × MIC ciprofloxacin or ceftazidime (32 μg/ml and
20 μg/ml respectively) was tracked over 30 h (Figure 3a). For
cultures incubated with ceftazidime, there was bacterial killing
for the first 8 h, but further incubation revealed a surviving
antibiotic tolerant population at a frequency of approximately
10− 3 (0.1%). A similar frequency of drug-tolerant persister cells
was observed following ciprofloxacin treatment after 24 h. Re-
streaking antibiotic-treated cultures on to LB agar or LB agar
plus antibiotic revealed growth on LB agar, but not on LB
agar containing antibiotic (results not shown), confirming that
the survivors were not antibiotic-resistant mutants.
The induction of hicA expression increased the frequency
of bacteria surviving ciprofloxacin exposure, in an arabinose
concentration-dependent manner, from approximately 10− 5
(under hicA repressed conditions) to 10− 3 (0.1%) of the bacterial
population at the highest arabinose concentration (Figure 3b). The
frequency of ceftazidime survivors increased from less than 10− 6
(under hicA repressed conditions) to 10− 3 when hicA expression
was induced with 0.2% arabinose, but no increase in survi-
vors was seen at lower arabinose concentrations (Figure 3c).
An E. coli control strain harbouring empty vectors showed
no alteration in persister frequency when supplemented with
either sugar (results not shown). Therefore overexpression of
B. pseudomallei hicA in E. coli increased ciprofloxacin and
ceftazidime persister frequencies. Furthermore, the differences
in the dependency of persister frequencies to antibiotics with
different mode of actions on HicA expression levels suggests that
ceftazidime and ciprofloxacin persisters might represent different
populations that are generated by a different mechanism.
Deletion of hicAB or overexpression of hicA in B. pseudomallei
differentially modifies ceftazidime or ciprofloxacin persister cell
frequencies
We next investigated the effect of deletion of the hicAB locus in B.
pseudomallei. When B. pseudomallei K96243 or B. pseudomallei
K96243 hicAB early stationary phase samples were exposed
to 100 × MIC of ciprofloxacin for 24 h, the hicAB mutant
had reduced persister frequencies of 7-fold compared with the
wild-type (P < 0.05, Wilcoxon matched-pairs signed rank test;
Figure 4a). In contrast, when these strains were exposed to
100 × MIC ceftazidime for 24 h, there was no difference in
persister cell frequencies (Figure 4b).
In spite of the evidence linking TA systems with persistence, the
deletion of individual TA modules rarely results in a reduction in
persister cell frequencies. This has been attributed to redundancy
between TA systems [45] and the deletion of multiple TA systems
was needed to elicit a significant reduction in persister cell
frequency in E. coli MG1655 [46]. However, in M. tuberculosis a
change in persister frequency has been reported when individual
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Figure 3 Persister cell formation in E. coli MG1655 encoding the hicA toxin cloned into pBAD/His and the hicB antitoxin cloned into pME6032
Standardized exponential phase cultures were incubated with arabinose or glucose to induce or repress hicA expression respectively, before treating with antibiotic. (a) hicA was induced with 0.2 %
arabinose for 3 h and then incubated with 100 × MIC ciprofloxacin or ceftazidime and CFU tracked over 30 h. (b) hicA was repressed with 0.2 % glucose and induced with a range of arabinose
concentrations (0.002–0.2 %) for 3 h before treatment with 100 × MIC ciprofloxacin for 24 h. (c) As described for (b) except treatment was with 100 × MIC ceftazidime. In both (b) and (c), persister
frequencies were calculated as CFU numbers post-antibiotic treatment divided by CFU numbers pre-antibiotic treatment. The data are shown as the means +− S.E.M. for three biological repeats.
***P < 0.001, as determined using one-way ANOVA with Tukey’s post test. ND, no detectable colonies.
relE genes were inactivated [20]. Also, deletion of the mqsR
toxin gene or mqsRA TA pair in E. coli BW52133 reduced
persister frequencies following ampicillin treatment by 6- and
7-fold respectively [47]. Our finding that deletion of hicBA in
B. pseudomallei only affects the survival towards one class
of antibiotic also suggests that ceftazidime and ciprofloxacin
persisters are different subpopulations.
Next, hicA was overexpressed in B. pseudomallei hicAB.
The plasmid cloned hicA gene was repressed or expressed
after the addition of 0.2% glucose or 0.2% rhamnose
for 4 h and standardized cultures were then incubated with
100 × MIC ciprofloxacin or 100 × MIC ceftazidime. When hicA
expression was repressed, the number of culturable cells following
ciprofloxacin treatment was below the limit of detection (<100
CFU), indicating a persister frequency of <10− 7 (Figure 4c).
When hicA expression was induced with rhamnose, the frequency
of persister cells increased significantly (P < 0.001, as determined
using a Student’s t test) to approximately 10− 2. Similarly,
after exposure of cultures to ceftazidime the frequency of
culturable cells increased significantly (P < 0.001, as determined
using a Student’s t test) from approximately 10− 4 in hicA-
repressed cultures to 10− 1 in hicA-induced cultures (Figure 4d).
B. pseudomallei hicAB harbouring empty pSCrhaB3 showed
no difference in survival following exposure to 100 × MIC
ciprofloxacin or 100 × MIC ceftazidime when grown in medium
containing either 0.2% glucose or 0.2% rhamnose (results not
shown).
Our findings that toxin overexpression increased persister
frequencies are similar to the results reported by other workers.
For instance, expression of RelE in E. coli increased the number of
persisters to cefotaxime, ofloxacin or tobramycin by 10–10000-
fold [48], whereas overexpression of HipA increased persisters
by 10000-fold [19]. Overexpression of RelE in M. tuberculosis
increased persister frequencies up to 13-fold [20]. In contrast with
E. coli, HicB expression was not required to re-awaken or reveal
B. pseudomallei persisters in our experiments. Our results likely
reflect the greater potency of the HicA toxin when expressed in
E. coli. More broadly, our results are similar to those reported by
Keren et al. [48] where RelB expression was not needed to reveal
persisters in a RelE-induced E. coli ΔrelBE strain.
One of the key findings from the present study is the differential
role of HicA in the frequency of persister cells towards two
different antibiotics. We showed that the low level expression
of hicA in E. coli resulted in an increase in ciprofloxacin persister
cells, but high level expression of hicA was necessary for an
increase in ceftazidime persister cells. Similarly, the deletion of
hicAB in B. pseudomallei reduced the number of ciprofloxacin
persisters, but did not affect the numbers of bacteria surviving
ceftazidime treatment. Previously, Singh et al. [20] reported that
three RelE homologues in M. tuberculosis had different roles in
promoting survival towards different antibiotics. It was suggested
that this reflected differences in the RNA target specificity of
these toxins. It is possible that our findings reflect the differential
cleavage of mRNA which was dependent on the concentration of
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Figure 4 Effect of deletion or overexpression of hicA on persister cell formation in B. pseudomallei K96243
(a and b) Stationary phase B. pseudomallei K96243 or B. pseudomallei K96243 hicAB treated with 100 × MIC (200 μg/ml) ciprofloxacin (a) or ceftazidime (b) respectively for 24 h. The data
are shown as the means +− S.E.M for at least three biological repeats. *P < 0.05, as determined using a Wilcoxon matched-pairs signed rank test. (c and d) Cultures of B. pseudomallei K96243
hicAB with pSCrhaB3 cloned hicA were grown to early exponential phase before repressing or inducing expression of hicA with 0.2 % glucose or 0.2 % rhamnose for 4 h. Standardized cultures
were then exposed to 100 × MIC ciprofloxacin (c) or ceftazidime (d) respectively for 24 h. Persister frequencies were calculated as CFU numbers post-antibiotic treatment divided by CFU numbers
pre-antibiotic treatment. The data are shown as the means +− S.E.M. for at least three biological repeats. ***P < 0.001, as determined a Student’s t test. ND, no detectable colonies; wt, wild-type.
HicA. Overall, our findings support an increasing understanding
of the complexity of the relationship between toxin expression
and survival towards different antibiotics.
His24 and Gly22 are important for HicA toxicity
To identify potential catalytic residues, the sequence of HicA was
aligned with 75 other sequences of proteins identified as potential
homologues (E value <0.0001) (Supplementary Figure S1 at
http://www.biochemj.org/bj/459/bj4590333add.htm). In total, 14
residues were at least 80% conserved (Figure 5). The histidine
residue at position 24 in HicA was most highly conserved. Using
site-directed mutagenesis, His24, Gly22, Gly14, Ser23 and Pro41 were
individually changed to alanine or cysteine. The toxic activity of
the proteins was assessed by measuring the change in the number
of culturable bacteria following expression of the mutant alleles in
E. coli MG1655. Cultures of E. coli expressing the G14C, S23A
or P41A mutants showed a decrease in the number of culturable
cells, which was comparable with E. coli expressing wild-type
hicA (Figure 6a). In contrast, E. coli expressing the G22C or
H24A mutants grew similarly to control E. coli cells harbouring
the empty pBAD/His plasmid. The difference between the viable
counts of E. coli expressing G22C or H24A compared with E. coli
expressing wild-type HicA was significant (P < 0.01 or P < 0.001,
as determined using a one-way ANOVA Dunnett’s post-test) and
expression of the non-toxic alleles was confirmed by Western
blotting. In summary, we have identified two residues, Gly22 and
His24, which play a role in HicA toxicity.
Gly14, Ser23 and Pro41 do not have a role in antitoxin binding
Even though the G14C, S23A and P41A mutations had no effect
on toxicity, the residues might have been important for antitoxin
binding. Therefore all three mutants were tested in a co-expression
assay in E. coli, where the wild-type or mutant toxin alleles
were cloned into pBAD/His and the hicB antitoxin gene was
cloned into pME6032. After induction of both the TA genes,
culturable bacteria were enumerated after plating on to agar. The
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Figure 5 Graphical representation of the amino acid residues in 75 homologous HicA sequences following sequence alignment
The amino acid sequence of B. pseudomallei K96243 HicA. The asterisks (*) and crosses ( × ) indicate >90 % and >80 % amino acid conservation respectively. Residues that were chosen for
mutagenesis are underlined. Sequences were aligned using Clustal Omega [47] and the graphic generated using Web logo [48].
number of culturable bacteria was similar for E. coli expressing
wild-type HicA or the G14C, S23A or P41A variants (results
not shown). Expression of the mutant alleles was confirmed by
Western blotting (results not shown).
His24 and Gly22 are important in the persister phenotype
Finally, the mutant toxin alleles were tested for their abilities
to modulate persister cell frequencies. E. coli strains harbouring
individual site-directed mutants of the HicA toxin (cloned into
pBAD/His) and pME6032-hicB were grown to early exponential
phase. Expression of the toxin genes was induced with 0.2 %
arabinose for 3 h. Cultures were then standardized and incubated
with 100 × MIC of ciprofloxacin or 100 × MIC of ceftazidime
for 24 h. E. coli expressing the toxic G14C, S23A or P41A alleles
had persister frequencies similar to the positive hicA control strain
following ciprofloxacin or ceftazidime treatment (Figure 6c and
6d respectively). In contrast, expression of the non-toxic H24A
and G22C alleles in E. coli resulted in persister frequencies
similar to the empty vector control following ciprofloxacin or
ceftazidime treatment and significantly different to frequencies
in E. coli expressing hicA (P < 0.001, as determined using a
one-way ANOVA Dunnett’s post-test). In summary, only the two
residues that are required for HicA-mediated bacteriostatis, Gly22
and His24, also play a role in inducing persister cell formation.
The structure of HicA forms a dsRBD-like (dsRNA-binding
domain-like) fold
The identification of a stable non-toxic variant form of HicA
allowed us to overexpress the protein and determine the structure
using NMR. Previously, information on the likely structure of
HicA toxins has been derived from the reported structure
of TTHA1913, a protein of unknown function from Thermus
thermophilus, which on the basis of a sequence alignment belongs
to the HicA family [49].
The hicA(H24A) mutant gene expressed in pBAD/His was not
toxic to E. coli and therefore the HicA(H24A) protein could
be purified in sufficient quantities for structure determination
by NMR (Figure 7). 13C,15N-double-labelled HicA(H24A) was
prepared in order to conduct triple-resonance experiments for
resonance assignment and restraint generation. Unfortunately,
the 13C-labelling was not uniform; backbone carbonyl atoms as
well as certain side-chain carbon atoms (e.g. valine, leucine,
isoleucine and histidine Cβ , and proline Cδ) did not appear to
be labelled above the natural abundance level. It is currently
unclear where the natural abundance carbon source stems
from; however, repeated expression gave the same result and
further studies are required to investigate whether HicA(H24A)
is having other unforeseen effects on E. coli metabolism.
Resonance assignment was thus hampered by the fact that
HNCO-based experiments could not be used and numerous
side-chain sites lack assignments (Supplementary Table S1
at http://www.biochemj.org/bj/459/bj4590333add.htm). It was
nonetheless possible to derive sufficient numbers of NOEs to
calculate a high-quality structure of HicA(H24A) (Supplementary
Table S1). As predicted previously [49], HicA toxin forms a
dsRBD-like fold consisting of a triple-stranded β-sheet with two
α-helices packed against one of its faces (Figures 7a and 7b). The
long loop connecting the β3 strand with the α2 helix is ill-defined
due to a lack of NOEs, suggesting that this loop occupies multiple
conformations in solution. The hydrophobic core is formed by
Leu10, Trp15, Phe27, Val36, Val38, Ile53 and Ala57 (Figure 7c), most
of which are highly conserved among HicA paralogues. Of the
residues used in site-directed mutagenesis experiments, Gly22,
Ser23 and H24A are located in the turn between the first and second
β-strands. Not all the Gly22 and Ser23 resonances are visible in the
spectra indicative of increased local dynamics in this short turn.
Pro41 is located in the nearby long unstructured β3-α2 loop. Gly14,
by contrast, is positioned at the other end of the molecule near the
start of the β1 strand. The surface of the HicA protein is highly
positively charged (Figure 7d).
The structure we report in the present study provides insights
into the structural or catalytic roles of amino acids which are
conserved across the HicA family of proteins. The β1-β2 and
β3-α2 loops contain several conserved residues (Gly22, Ser23
and His24 in β1-β2 and Pro39, Pro41, Asp44 and Gly48 in β3-
α2), suggesting that it is primarily this end of the molecule
which is involved in catalysis and binding of the substrate and
antitoxin. His24 and Gly22 probably have important catalytic
and structural roles in the HicA–substrate complex. Surprisingly,
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Figure 6 Functional analysis of site-directed hicA mutants
(a) Fold change in the number of culturable E. coli MG1655 cells harbouring pBAD/His or pBAD/His encoding wild-type hicA or mutant alleles. Cultures were grown to early exponential phase
before inducing expression of hicA or mutants with 0.2 % arabinose for 2 h. The data are shown as the means +− S.E.M. for three biological repeats. **P < 0.01, ***P < 0.001 and ****P < 0.0001,
as determined using one-way ANOVA and Dunnett’s post-test, comparing the means with HicA. (b) Western blot of E. coli-expressing H24A (lanes 1 and 2) or G22C (lanes 3 and 4) HicA variants
under glucose-repressed (lanes 1 or 3) or arabinose-induced (lane 2 and 4) conditions. The reactive band size is 13 kDa. The molecular mass (M) is indicated in kDa on the left-hand side. (c and
d) Persister cell formation by E. coli MG1655 expressing wild-type HicA or HicA mutants after 100 × MIC antibiotic treatment. Cultures were grown to early exponential phase before inducing
expression of the toxin or toxin mutants. Standardized cultures were incubated with 100 × MIC of ciprofloxacin (c) or ceftazidime (d) for 24 h in a 24-well plate at 37◦C. After washing, cells were
plated on to LB agar. Persister frequency was calculated as CFU counts post antibiotic treatment divided by CFU counts pre-treatment. The data are shown as the means +− S.E.M. for three biological
repeats. ***P < 0.001, as determined using a one-way ANOVA with a Dunett’s post-test, comparing the means with HicA. ND, no detectable colonies.
the S23A mutation did not modify HicA function, despite the high
degree of sequence conservation at this site and its proximity to
Gly22 and His24. Several other conserved residues are likely to
have a structural role by contributing to the hydrophobic core
of the protein (Leu10, Trp15, Ile53 and Ala57). Gly14 is conserved,
but our mutational studies show that it appears not to have a
functional role. However, it occupies an unusual area of the
Ramachandran plot, which although is accessible to other residues
may be thermodynamically more stable for glycine residues.
Roles for Lys55 and Gly58 remain unclear. Further (possibly
double) mutations or HicA–HicB and HicA–substrate complex
structures may be required to elucidate their function and confirm
the active site.
At least eight known toxins exhibit RNase activity, although
their structures, specificities and mechanisms vary [23,50]. For
example, Zhu et al. [51] have reported that different MazF
homologues from M. tuberculosis recognize different RNA
sequence pentads, whereas RelE toxins preferentially cut codons
between the second and third position of the binding site and
upstream of a purine [52]. A previous study reported that RNase
activity was associated with E. coli HicA [27]. However, it was
unclear whether this was a result of a direct interaction between
HicA and target RNA. We have shown His24 to be critical to
the function of HicA which is consistent with RNase activity
(the Catalytic Site Atlas [53] shows all known RNase active
sites to contain at least one histidine residue). Further support
for RNase activity comes from a model in which RNA was
docked on to the PI-PfuI structure showing the RNA-binding
site extending from a large endonuclease domain on to the middle
domain where binding occurs across the β3-α2 loop and the top
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Figure 7 Structure analysis of HicA
(a) Structure of the HicA(H24A) protein with the positions of the five residues that were selected for mutagenesis coloured blue. The N- and C-termini and secondary structure elements are indicated.
(b) Ensemble of ten calculated structures of HicA(H24A). Disordered residues (as calculated by PSVS 1.4 [34]) are coloured grey. (c) Structure of HicA(H24A) with side chains of conserved residues
shown as sticks (blue and yellow); yellow residues contribute to the hydrophobic core, as do Val36 and Val38 and Phe27, indicated as red sticks. Residues 6–2 have been omitted from all panels, as
they are completely unstructured. (d) Charge distribution of the surface of HicA(H24A). Regions of positive, negative and no charge are coloured blue, red and white respectively. (e) Superimposition
of HicA(H24A) (red) with TTHA1913 from T. thermophilus (blue; PDB code 1WHZ).
of the β-sheet [54]. Investigation of the charge distribution on the
surface of H24A HicA shows the protein to be highly positively
charged, especially across the β3-α2 and β1-β2 loops and the
back of the β-sheet. A comparison of the structure and highly
conserved residues does not suggest the obvious involvement of
other histidine, lysine, glutamic acid or arginine residues in the
possible RNase activity of His24. However, our HicA does contain
a further histidine at residue 26 and many others contain one at
residue 40 which is close in space to His24.
The closest structural homologues to HicA(H24A) are members
of the YcfA/nrd intein domain superfamily: the middle (or stirrup)
domain of PI-PfuI (PDB code 1DQ3) [55], the hypothetical
protein TTHA1913 from T. thermophilus (PDB code 1WHZ),
and the hypothetical protein YkfF from E. coli (PDB code
2HJJ). The structure is most closely related to that of TTHA1913
from T. thermophilus (Figure 7e), belonging to the YcfA-like
family of protein structures in the SCOP classification [56].
Since TTHA1913 could be expressed and purified from E. coli
for structure determination, whereas the expression of the B.
pseudomallei HicA protein in E. coli was toxic [21,27], it seems
likely that TTHA1913 is a non-toxic HicA homologue. However,
comparison of the sequences and structures do not provide a
clear indication of why TTHA1913 is not toxic to E. coli. Major
structural differences lie between the unstructured β3-α2 loop
(although sequence differences tend to be conservative) and the
C-terminus; TTHA1913 has an additional C-terminal helix that
is not present in HicA. The location of this helix, however, is
near a negatively charged patch on the surface of the protein and
distant from the β3-α2 and β1-β2 loops thought to be important
in substrate binding.
In summary, we have demonstrated a role for the HicAB system
in bacterial persistence and have demonstrated that bacterial
persistence towards two different antibiotics is differentially
dependent on HicA. This important finding provides a new insight
into the phenomenon of multidrug resistance in persister cells. It
is likely that this is only one of many mechanisms that regulate
persister cell formation in B. pseudomallei. Finally, the structure
we have obtained is the first of a HicA family protein which is
proven to have toxic activity and our work provides new insight
into structure–function relationships in this class of toxins.
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SUPPLEMENTARY ONLINE DATA
The HicA toxin from Burkholderia pseudomallei has a role in persister cell
formation
Aaron BUTT*, Victoria A. HIGMAN†, Christopher WILLIAMS†, Matthew P. CRUMP†, Claudia M. HEMSLEY*, Nicholas HARMER*
and Richard W. TITBALL*1
*Biosciences, College of Life and Environmental Sciences, University of Exeter, Geoffrey Pope Building, Stocker Road, Exeter EX4 4QD, U.K.
†School of Chemistry, University of Bristol, Cantock’s Close, Bristol BS8 1TS, U.K.
Table S1 NMR assignment, structure calculation and validation statistics
Parameter Values
Degree of assignment*
Backbone (Cα, C’, N and HN) (%) 91.2
Side-chain H (%) 79.4
Side-chain non-H (%) 39.7
Number of restraints
Distance restraints
Intra-residue (|i − j| = 0) 515
Sequential (|i − j| = 1) 216
Medium range (2|i − j|<5) 109
Long range (|i − j|5) 172
Ambiguous 59
Total 1012
Dihedral angle restraints (/) 94 (47/47)
Restraint statistics†
RMSD of distance violations (Å) 0.019 +− 0.003
RMSD of dihedral violations (◦) 0.27
Violations>0.5 Å 0
Violations>0.3 Å 0
Violations>0.1 Å 9.8 +− 2.8
RMSD from idealized covalent geometry†
Bonds (Å) 0.0031 +− 0.00017
Angles (◦) 0.47 +− 0.0013
Impropers (◦) 1.33 +− 4.97
Structural quality
Ramachandran statistics*‡§
Most favoured regions (%) 84.0 91.2
Allowed regions (%) 14.2/7.0
Generously allowed regions (%) 1.9/1.8
Disallowed regions (%) 0.0/0.0
CING ROG scores (R/O/G)* [1] (%) 20/22/58
Verify3D Z-score [2] − 2.57
Prosa II Z-score [3] − 0.74
Procheck Z-score (/)‡ [4] − 1.14
Procheck Z-score (/)‡ [4] − 1.71
MolProbity Z-score [5] − 1.57
Number of close contacts 2
Co-ordinates precision (RMSD)*§‖
All backbone atoms (Å) 3.2/1.2/0.6
All heavy atoms (Å) 3.5/1.6/1.4
*Residues 5–59.
†Values reported by ARIA 2.3 [6].
‡Values reported by Procheck [4].
§Ordered residues (5–21, 23–32, 35–39 and 45–58) as calculated by PSVS 1.4 [3].
‖Residues in secondary structure (6–12, 16–19, 24–28, 35–39 and 50–58) as determined
by DSSP [7].
1 To whom correspondence should be addressed (email r.w.titball@exeter.ac.uk).
The chemical shifts and structure reported for HicA toxin from Burkholderia pseudomallei will appear in the Biological Magnetic Resonance Data Bank
(BMRB) under accession number 19464 and in the PDB under code 4C26 respectively.
c© The Authors Journal compilation c© 2014 Biochemical Society























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure S1 List of 75 HicA homologous sequences from differerent bacterial strains
These sequences were used for a subsequent ClustalW alignment and the most conserved residues are shown. A high-resolution version of Figure S1 is available to download (at
http://www.biochemj.org/bj/459/bj4590333add.htm).
c© The Authors Journal compilation c© 2014 Biochemical Society
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